4:29 PM
 | 
Jun 14, 2017
 |  BC Extra  |  Financial News

Athenex ticks up after $66M IPO

Editor's Note: This article was updated on Jun 27, 2017 at 1:59 PM PDT

Cancer company Athenex Inc. (NASDAQ:ATNX) gained $1.56 (14%) to $12.56 in its first day of trading Thursday after it raised $66 million through the sale of 6 million shares at $11 in an IPO underwritten by Credit Suisse, Deutsche Bank, JPMorgan, and ICBC International Securities. The...

Read the full 213 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >